首页 / 专利分类库 / 有机化学 / 甾族化合物 / 含有碳、氢、卤素或氧的立体化学纯的甾族化合物,并且有部分或全部转化骨架,例如反甾族化合物,L-异构体类
序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
181 SIALYLTRANSFERASE INHIBITORS AND USES THEREOF EP16840229.5 2016-08-26 EP3341387A1 2018-07-04 LI, Wen-Shan; HUNG, Wen-Chun; SHEN, Chia-Ning
Disclosed herein are novel sialyltransferase inhibitors, and compositions and methods for treating diseases and/or conditions associated with the activation of sialyltransferase, such as a cancer, an immune disease or an inflammatory disease.
182 16-Hydroxyestratriene als selektiv wirksame Estrogene EP05075149.4 2000-02-09 EP1580192A2 2005-09-28 Künzer, Hermann, Dr.; Knauthe, Rudolf, Dr.; Lessl, Monika, Dr.; Fritzemeier, Karl-Heinrich, Dr.; Hegele-Hartung, Christa, Dr.; Bömer, Ulf, Dr.; Müller, Gerd, Dr.; Kosemund, Dirk, Dr.

Die Erfindung beschreibt neue Verbindungen als pharmazeutische Wirkstoffe, die in vitro eine höhere Affinität an Estrogenrezeptorpräparationen von Rattenprostata als an Estrogenrezeptorpräparationen von Rattenuterus und in vivo eine präferentielle Wirkung am Knochen im Vergleich zum Uterus und/oder ausgeprägte Wirkung hinsichtlich Stimulierung der Expression von 5HT2a-Rezeptor und -transporter aufweisen, deren Herstellung, ihre therapeutische Anwendung und pharmazeutischen Darreichungsformen, die die neuen Verbindungen enthalten.

Bei den neuen Verbindungen handelt es sich um 16α- und 16β-Hydroxy-estra,1,3,5(10)-estratriene, die am Steroid-Gerüst weitere Substituenten tragen sowie in den B-, C-und/oder D-Ringen eine oder mehrere zusätzliche Doppelbindungen aufweisen können.

183 Pharmaceutical compositions having appetite suppressant activity EP02004101.8 1998-04-15 EP1213020A3 2005-03-09 Van Heerden, Fanie Retief; Vleggaar, Robert; Horak, Roelof Marthinus; Learmonth, Robin Alec; Maharaj, Vinesh; Whittal, Rory Desmond

The present invention relates to a surface cutting apparatus for hot-rolled steel products for cutting the top and bottom surfaces of a hot-rolled steel product continuously or intermittently by passing said steel product between a pair of rotary drums (38a,38b) rotating in the direction reverse to each other, said apparatus having a disk (39a,39b) for recognizing a gap between the rotary drums (38a,38b), which has a diameter larger than that of said rotary drum, at both ends or one end of at least one rotary drum (38a,38b).

184 Use of extracts from Hoodia gordonii and Hoodia lugardii for the preparation of a medicament for use in the suppression of appetite EP04002070.3 1998-04-15 EP1438965A1 2004-07-21 van Heerden, Fanie Retief; Vleggaar, Robert; Horak, Roelof Marthinus; Learmonth, Robin Alec; Maharaj, Vinesh; Whittal, Rory Desmond

Extracts obtainable from Hoodia gordonii or lugardii containing an appetite suppressant agent having the formula (1) are disclosed for the manufacture of medicaments having appetite suppressant activity.

185 Pharmaceutical compositions having appetite suppressant activity EP02004101.8 1998-04-15 EP1213020A8 2003-12-17 Van Heerden, Fanie Retief; Vleggaar, Robert; Horak, Roelof Marthinus; Learmonth, Robin Alec; Maharaj, Vinesh; Whittal, Rory Desmond

A pharmaceutical composition contains an extract obtainable from a plant of the genus Trichocaulon or Hoodia containing an appetite suppressant agent having the formula (1). A process for obtaining the extract and a process for synthesizing compound (1) and it analogues and derivatives is also provided. The invention also extends to the use of such extracts and compound (1) and its analogues for the manufacture of medicaments having appetite suppressant activity. The invention further provides novel intermediates for the synthesis of compound (1).

186 14$g(b)-H-STEROLS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND USE OF THESE DERIVATIVES FOR THE PREPARATION OF MEIOSIS REGULATING MEDICAMENTS EP00929510.6 2000-05-05 EP1177205A1 2002-02-06 ESPERLING, Peter; KUHNKE, Joachim; LAURENT, Henry; BLUME, Thorsten; HEGELE-HARTUNG, Christa; LESSL, Monika
The present invention relates to pharmaceutically active 14β-H-sterols, to pharmaceutical compositions comprising them and to the use of these novel compounds for the preparation of medicaments. More particularly it has been found that the 14β-H-sterols of the invention can be used for regulating meiosis.
187 Improved process for the preparation of 3 beta, 14 beta-dihydroxyethialnaldehyde EP95830069.1 1995-03-03 EP0684256B1 1998-05-13 Gobbini, Mauro; Torri, Marco
188 13-Alkyl-11Beta-phenylgonane EP89730155.2 1989-07-03 EP0349481B1 1995-11-02 Scholz, Stefan, Dr.; Ottow, Eckhard, Dr.; Neef, Günter, Dr.; Elger, Walter, Dr.; Beier, Sybille, Dr.; Chwalisz, Krzysztof, Dr.
189 EP0669931A4 - EP94902304 1993-11-18 EP0669931A4 1995-10-04
190 Method of preparating 9beta, 10alpha-5,7-diene steroids EP93200423.7 1993-02-16 EP0558119A2 1993-09-01 Bout, Berthus; Voorhaar, Ronald

The invention relates to a method of preparing a 9beta,10alpha-5,7-diene steroid by irradiating the corresponding 9alpha,10beta-5,7-diene steroid with filtered ultraviolet light from an indium lamp.

191 New ll-aryl steroid derivatives EP88200071.4 1988-01-18 EP0277676B1 1992-03-04 Loozen, Hubert Jan Jozef
192 11Beta-phenyl-14betaH-steroide EP89250040.6 1989-09-20 EP0360369A1 1990-03-28 Scholz, Stefan, Dr.; Neef, Günter, Dr.; Ottow, Eckhard, Dr.; Elger, Walter, Dr.; Beier, Sybille, Dr.; Chwalisz, Krzysztof, Dr.

Neue 11β-Phenyl-14ßH-steroide der allgemeinen Formel l worin

  • Z für Sauerstoffatom oder die Hydroxyiminogruppierung N~OH sowie
  • L und M entweder gemeinsam für eine zweite Bindung oder L für ein Wasserstoffatom und M für eine α-ständige Hydroxygruppe stehen und entweder A und B zusammen eine zweite Bindung und D ein Wasserstoffatom bedeuten, wobei
  • R' für einen fünf- oder sechsgliedrigen Heteroarylrest oder für einen Cycloalkyl-, Cycloalkenyl- oder Arylrest steht
  • oder aber A ein Wasserstoffatom und B und D zusammen eine Methylenbrücke bedeuten, wobei
  • R1 außer den genannten Resten zusätzlich ein gegebenenfalls substituierter Kohlenwasserstoffrest mit bis zu 10 C-Atomen, eine gegebenenfalls substituierte Aminogruppe, eine Hydroxy- oder C1-8-Alkoxy-, eine Mercapto- oder Thioalkylgruppe sein kann,
  • R2 für einen Methyl- oder Ethylrest sowie
  • R3,R4- für die in der Steroidchemie am C17-Atom üblichen Substituentenkombinationen stehen,
  • besitzen u.a. antigestagene Eigenschaften.

193 13-Alkyl-11Beta-phenylgonane EP89730155.2 1989-07-03 EP0349481A1 1990-01-03 Scholz, Stefan, Dr.; Ottow, Eckhard, Dr.; Neef, Günter, Dr.; Elger, Walter, Dr.; Beier, Sybille, Dr.; Chwalisz, Krzysztof, Dr.

Es werden 13-Alkyl-11ß-phenyl-gonane der allgemeinen Formel I beschrieben,

worin Z, R¹, R², R³ und R⁴ die in der Beschreibung angegebene Bedeutung haben, Verfahren zu deren Herstellung, Pharmazeutische Präparate, die diese Verbindungen enthalten sowie ihre Verwendung zur Herstellung von Arzneimitteln.

Die neuen Verbindungen der allgemeinen Formel I besitzen hervorragende antigestagene Wirksamkeit.

194 Method of preparing 9beta,10alpha-5,7-diene-steroids EP85200115.5 1985-02-04 EP0152138B1 1988-01-13 Rappoldt, Menso P.; Mos, Gerardus H.M.
195 11-Beta phenyl gonanes, their preparation and pharmaceutical compositions containing them EP86101548 1986-02-06 EP0190759A3 1986-11-20 Neef, Günter, Dr.; Wiechert, Rudolf, Prof.; Ottow, Eckard, Dr.; Rohde, Ralph. Dr.; Beier, Sybille, Dr.; Elger, Walter, Dr.; Henderson, David, Dr.
196 11 Beta-Phenyl-Gonane, deren Herstellung und diese enthaltende pharmazeutische Präparate EP86101548.5 1986-02-06 EP0190759A2 1986-08-13 Neef, Günter, Dr.; Wiechert, Rudolf, Prof.; Ottow, Eckard, Dr.; Rohde, Ralph. Dr.; Beier, Sybille, Dr.; Elger, Walter, Dr.; Henderson, David, Dr.

Es warden neve 13-Alkyl-11ß-phenyl-gonane der allgemeinen Formel worin

  • A und B gemeinsam für ein Sauerstoffatom, eine CH2-Gruppe oder eine zweite Bindung zwischen den Kohlenstoffatomen 9 und 10,
  • X für ein Sauerstoffatom oder die Hydroxyiminogruppierung N CH,
  • R1 für einen geradkettigen oder verzweigten, gesättigten oder ungesättigten Kohlenwasserstoffrest mit bis zu (8) Kohlenstoffatomen, der die Gruppierung mit X in der oben genannten Bedeutung enthalten soll,
  • R2 für einen- oder ß-ständigen Methyl- oder Ethylrest,
  • R9, R10 R11 und R12 jeweils für ein Wasserstoffatom, eine Hyroxy-,Alkyl-, Alkoxy- oder Acyloxygruppe mit jeweils 1 bis 4 Kohlenstoffatomen oder ein Halogenatom stehen und
  • R3 und R4 verschiedene Bedeutungen haben.

Die neuen 11ß-Phenyl-Gonane besitzen antigestagene und antiglucocorticoide Wirkungen.

197 New 8-alpha-oestra-1,3,5(10)-triene derivatives, processes for their preparation and pharmaceutical compositions EP81200741.7 1981-07-01 EP0044105A2 1982-01-20 Groen, Marinus Bernard, Dr.

The invention relates to new 8a-oestra-1,3,5(10)-triene derivatives having the formula: in which

  • R, = H or a free, esterified or etherified hydroxy group; R2 = H or a free, esterified or etherified hydroxy group, with the proviso that at least one of the substituents R1 and R2 is different from H;
  • R3 alkyl (1-4 C) and
  • R4 = 0 or (aX) (βY), in which
  • X = H or aliphatic hydrocarbyl (1-4 C) and
  • Y = a free, esterified or etherified hydroxy group and the enantiomers and racemic mixtures thereof, and also extends to processes for their preparation and to pharmaceutical compositions containing said new compounds.

198 STEROIDS AND METHODS OF MANUFACTURE US17818873 2022-08-10 US20230018615A1 2023-01-19 Glenn C. Micalizio
Methods for producing enantiodefined polycyclic compounds, particularly tetracyclic compounds, are provided. More particularly, synthetic methods for producing biologically active enantiodefined steroidal compositions of both natural (“nat-”) and unnatural (“ent-”) absolute stereochemistry are provided. An exemplary method for manufacturing a tetracyclic compound comprises a step of forming a hydrindane intermediate through coupling of a suitably functionalized enyne with a suitably functionalized alkyne and subsequently performing an intramolecular ring-closing reaction to form the tetracyclic compound. Steroidal compounds obtained by this method and methods of using such steroidal compounds in human and/or animal therapeutics and medicines are also provided.
199 Steroids and methods of manufacture US16637675 2018-08-16 US11459353B2 2022-10-04 Glenn C. Micalizio
Methods for producing enantiodefined polycyclic compounds, particularly tetracyclic compounds, are provided. More particularly, synthetic methods for producing biologically active enantiodefined steroidal compositions of both natural (“nat-”) and unnatural (“ent-”) absolute stereochemistry are provided. An exemplary method for manufacturing a tetracyclic compound comprises a step of forming a hydrindane intermediate through coupling of a suitably functionalized enyne with a suitably functionalized alkyne and subsequently performing an intramolecular ring-closing reaction to form the tetracyclic compound. Steroidal compounds obtained by this method and methods of using such steroidal compounds in human and/or animal therapeutics and medicines are also provided.
200 19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF US17560732 2021-12-23 US20220110950A1 2022-04-14 Gabriel Martinez Botella; Boyd L. Harrison; Albert Jean Robichaud; Francesco G. Salituro; Richard Thomas Beresis
Provided herein are 19-nor C3,3-disubstituted C21-pyrazolyl steroids of Formula (I): and pharmaceutically acceptable salts thereof; wherein , R1, R2, R3a, R3b, R4a, R4b, R5, R6, and R7 are as defined herein. Such compounds are contemplated useful for the prevention and treatment of a variety of CNS-related conditions, for example, treatment of sleep disorders, mood disorders, schizophrenia spectrum disorders, convulsive disorders, disorders of memory and/or cognition, movement disorders, personality disorders, autism spectrum disorders, pain, traumatic brain injury, vascular diseases, substance abuse disorders and/or withdrawal syndromes, and tinnitus.
QQ群二维码
意见反馈